The Lung Cancer CEG comprises an enthusiastic and committed expert group of people, including clinicians with busy clinical practices and knowledge of the “front line”, nationally and internationally recognised academics, commissioners, patient and public representatives and nurses.
The National Cancer Clinical Steering Group have now formally approved the new clinical pathway advice produced by the Lung Cancer CEG. The purpose of these documents is to inform and support decision making by cancer alliances in relation to services and clinical pathways for lung cancer. The recommendations address the whole cancer pathway from prevention, early diagnosis, treatment and care to living with and beyond cancer.
The following documents are available for download HERE via the Roy Castle Lung Cancer Foundation who act as the secretariat